| Keywords: |
unclassified drug; cd8 antigen; cancer immunotherapy; dendritic cell; germ cell; carcinoma, non-small-cell lung; lung neoplasms; granulocyte macrophage colony stimulating factor; gene product; editorial; tumor cell culture; gene library; tumor antigen; enzyme linked immunosorbent assay; carcinogenesis; lung small cell cancer; immunotherapy; antigens, neoplasm; cancer testis antigen; melanoma antigen 3; ny eso 1 antigen; immunogenicity; antibody response; cancer immunization; western blotting; cd4 antigen; tumor growth; tumor vaccine; t lymphocyte activation; xage 1b antigen; target cell destruction
|
